|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ISRCTN |
|
Last refreshed on:
|
13 January 2015 |
|
Main ID: |
ISRCTN96523406 |
|
Date of registration:
|
12/09/2003 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Use of chlorhexidine gluconate 0.2% oral rinse (CHX) to reduce the incidence of nosocomial lower respiratory tract infections in intubated ICU adult patients
|
|
Scientific title:
|
Use of chlorhexidine gluconate 0.2% oral rinse (CHX) to reduce the incidence of nosocomial lower respiratory tract infections in intubated ICU adult patients |
|
Date of first enrolment:
|
01/08/2002 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Completed |
|
URL:
|
http://isrctn.com/ISRCTN96523406 |
|
Study type:
|
Interventional |
|
Study design:
|
Randomised controlled trial (Prevention)
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Jacqueline
Bailey |
|
Address:
|
ICU Department
Level 04
Derriford Hospital
PL6 8DH
Plymouth
United Kingdom |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Not provided at time of registration
Exclusion criteria: Not provided at time of registration
Age minimum:
Age maximum:
Gender:
Not Specified
|
|
Health Condition(s) or Problem(s) studied
|
Respiratory: Lower respiratory tract infection
Respiratory
Lower respiratory tract infection
|
|
Intervention(s)
|
|
We propose to administer 15 ml chlorhexidine gluconate or placebo to the buccal, pharangeal, gingival tongue, roof of mouth and tooth surfaces with a sponge swab twice daily to intubated patients who are predicted to require mechanical ventilation. Broncheoalveolar lavage specimen will be sent for culture every 48 h and the following clinical observations will be recorded daily - white cell count, sputum appearance, temperature and chest X-ray changes. The study ends once the patient is extubated but the observations will be recorded for a further 7 days.
|
|
Primary Outcome(s)
|
|
Not provided at time of registration
|
|
Secondary Outcome(s)
|
|
Not provided at time of registration
|
|
Secondary ID(s)
|
|
N0185116743
|
|
Source(s) of Monetary Support
|
|
Plymouth Hospitals NHS Trust (UK)
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|